Press Release: Sensorion : Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022
Regulatory News: Sensorion (FR0012596468 - ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of
Read full article »
Sensorion is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of inner ear diseases.
Read more